These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17680229)
1. Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases. Armstrong RA; Lantos PL; Cairns NJ J Neural Transm (Vienna); 2007; 114(12):1569-77. PubMed ID: 17680229 [TBL] [Abstract][Full Text] [Related]
2. Spatial patterns of the tau pathology in progressive supranuclear palsy. Armstrong RA; Cairns NJ Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688 [TBL] [Abstract][Full Text] [Related]
3. Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Armstrong RA; Lantos PL; Cairns NJ Clin Neuropathol; 2009; 28(1):46-53. PubMed ID: 19216220 [TBL] [Abstract][Full Text] [Related]
4. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy. Armstrong RA; Cairns NJ Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050 [TBL] [Abstract][Full Text] [Related]
5. White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Armstrong RA Clin Neuropathol; 2013; 32(5):399-405. PubMed ID: 23587170 [TBL] [Abstract][Full Text] [Related]
6. An autopsy case of PSP with astrocytic inclusions. Inagaki T; Ishino H; Seno H; Yamamori C; Iijima M Jpn J Psychiatry Neurol; 1994 Mar; 48(1):85-9. PubMed ID: 7933721 [TBL] [Abstract][Full Text] [Related]
7. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Armstrong RA; Lantos PL; Cairns NJ Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313 [TBL] [Abstract][Full Text] [Related]
8. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Togo T; Dickson DW Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627 [TBL] [Abstract][Full Text] [Related]
9. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707 [TBL] [Abstract][Full Text] [Related]
10. The relationship between histopathological features of progressive supranuclear palsy and disease duration. Josephs KA; Mandrekar JN; Dickson DW Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422 [TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death. Zhang L; Toyoshima Y; Takeshima A; Shimizu H; Tomita I; Onodera O; Takahashi H; Kakita A Neuropathology; 2021 Jun; 41(3):174-182. PubMed ID: 33205528 [TBL] [Abstract][Full Text] [Related]
12. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262 [TBL] [Abstract][Full Text] [Related]
13. Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. Takahashi M; Weidenheim KM; Dickson DW; Ksiezak-Reding H J Neuropathol Exp Neurol; 2002 Jan; 61(1):33-45. PubMed ID: 11829342 [TBL] [Abstract][Full Text] [Related]
14. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936 [TBL] [Abstract][Full Text] [Related]
16. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Allen M; Wang X; Serie DJ; Strickland SL; Burgess JD; Koga S; Younkin CS; Nguyen TT; Malphrus KG; Lincoln SJ; Alamprese M; Zhu K; Chang R; Carrasquillo MM; Kouri N; Murray ME; Reddy JS; Funk C; Price ND; Golde TE; Younkin SG; Asmann YW; Crook JE; Dickson DW; Ertekin-Taner N Acta Neuropathol; 2018 Nov; 136(5):709-727. PubMed ID: 30136084 [TBL] [Abstract][Full Text] [Related]
17. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Henderson JM; Carpenter K; Cartwright H; Halliday GM Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053 [TBL] [Abstract][Full Text] [Related]
18. Neurofibrillary pathology in progressive supranuclear palsy (PSP). Cervós-Navarro J; Schumacher K J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685 [TBL] [Abstract][Full Text] [Related]
19. [The reappraisal study of the ultrastructure of Alzheimer's neurofibrillary tangles in three cases of progressive supranuclear palsy]. Amano N; Iwabuchi K; Yokoi S; Yagishita S; Itoh Y; Saitoh A; Nagatomo H; Matsushita M No To Shinkei; 1989 Jan; 41(1):35-44. PubMed ID: 2655673 [TBL] [Abstract][Full Text] [Related]
20. [Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy]. Hitoshi S; Mizutani T; Amano N; Bando M; Yamanouchi H Rinsho Shinkeigaku; 1994 Jun; 34(6):557-62. PubMed ID: 7955713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]